Ceradyne, Inc. has reported financial results for the second quarter and six months ended June 30, 2006, including record sales and record net income. Sales for the second quarter of 2006 rose to a record $162 million, up from $89.9 million in the second quarter of 2005. Net income increased to a record $30 million, or $1.10 per diluted share. This compares to a net income of $11.4 million, or $.46 per diluted share, in the second quarter of 2005. Sales for the six months ended June 30, 2006, reached a record $298.4 million, up from $159.7 million in the comparable period last year. Net income for the first six months of 2006 increased to a record $54.6 million, or $2.00 per diluted share, from $17.4 million or $.70 per diluted share, for the first six months of 2005.
Our annual R&D Lab Equipment and Instrumentation Directory helps you locate the best suppliers for your needs. This issue also includes articles focused on deformation and tension, materials characterization trends, non-destructive imaging, and more. Check it out!